Industry Research Reports

Home > Reports > Service & Software > Pharmaceutical CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Pharmaceutical CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-01-19

Pages: 150 Pages

Report ld: 5726731

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Pharmaceutical CRO Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.

The North American market for Pharmaceutical CRO Services was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Pharmaceutical CRO Services was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Pharmaceutical CRO Services was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Pharmaceutical CRO Services market include PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, Parexel, ICON plc, Syneos Health, Charles River Laboratories, Medpace, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Pharmaceutical CRO Services, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Pharmaceutical CRO Services market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CRO Services.

MARKET SEGMENTATION

By Company

PPD (Thermo Fisher)
Space Peptides
Aurigene Pharmaceutical Services
IQVIA
Labcorp Drug Development
Parexel
ICON plc
Syneos Health
Charles River Laboratories
Medpace
SGS SA
KCR CRO
TFS HealthScience
Caidya
Worldwide Clinical Trials
CTI
Advanced Clinical
WuXi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
JOINN Laboratories
MEDICILON

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Preclinical CRO
Clinical Trial CRO

Segment by Application

Commercial
Scientific Research
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Pharmaceutical CRO Services companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Pharmaceutical CRO Services revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Pharmaceutical CRO Services revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Pharmaceutical CRO Services Product Introduction

1.2 Global Pharmaceutical CRO Services Market Size Forecast (2021–2032)

1.3 Pharmaceutical CRO Services Market Trends & Drivers

1.3.1 Pharmaceutical CRO Services Industry Trends

1.3.2 Pharmaceutical CRO Services Market Drivers & Opportunities

1.3.3 Pharmaceutical CRO Services Market Challenges

1.3.4 Pharmaceutical CRO Services Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pharmaceutical CRO Services Players Revenue Ranking (2025)

2.2 Global Pharmaceutical CRO Services Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Pharmaceutical CRO Services Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Pharmaceutical CRO Services

2.6 Pharmaceutical CRO Services Market Competitive Analysis

2.6.1 Pharmaceutical CRO Services Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Pharmaceutical CRO Services Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical CRO Services revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Pharmaceutical CRO Services Market Classification

3.1 Introduction by Type

3.1.1 Preclinical CRO

3.1.2 Clinical Trial CRO

3.1.3 Global Pharmaceutical CRO Services Sales Value by Type

3.1.3.1 Global Pharmaceutical CRO Services Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Pharmaceutical CRO Services Sales Value, by Type (2021–2032)

3.1.3.3 Global Pharmaceutical CRO Services Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Commercial

4.1.2 Scientific Research

4.1.3 Other

4.2 Global Pharmaceutical CRO Services Sales Value by Application

4.2.1 Global Pharmaceutical CRO Services Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Pharmaceutical CRO Services Sales Value by Application (2021–2032)

4.2.3 Global Pharmaceutical CRO Services Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Pharmaceutical CRO Services Sales Value by Region

5.1.1 Global Pharmaceutical CRO Services Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Pharmaceutical CRO Services Sales Value by Region (2021–2026)

5.1.3 Global Pharmaceutical CRO Services Sales Value by Region (2027–2032)

5.1.4 Global Pharmaceutical CRO Services Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Pharmaceutical CRO Services Sales Value, 2021–2032

5.2.2 North America Pharmaceutical CRO Services Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Pharmaceutical CRO Services Sales Value, 2021–2032

5.3.2 Europe Pharmaceutical CRO Services Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Pharmaceutical CRO Services Sales Value, 2021–2032

5.4.2 Asia Pacific Pharmaceutical CRO Services Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Pharmaceutical CRO Services Sales Value, 2021–2032

5.5.2 South America Pharmaceutical CRO Services Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Pharmaceutical CRO Services Sales Value, 2021–2032

5.6.2 Middle East & Africa Pharmaceutical CRO Services Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pharmaceutical CRO Services Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Pharmaceutical CRO Services Sales Value, 2021–2032

6.3 United States

6.3.1 United States Pharmaceutical CRO Services Sales Value, 2021–2032

6.3.2 United States Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Pharmaceutical CRO Services Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Pharmaceutical CRO Services Sales Value, 2021–2032

6.4.2 Europe Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Pharmaceutical CRO Services Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Pharmaceutical CRO Services Sales Value, 2021–2032

6.5.2 China Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

6.5.3 China Pharmaceutical CRO Services Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Pharmaceutical CRO Services Sales Value, 2021–2032

6.6.2 Japan Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Pharmaceutical CRO Services Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Pharmaceutical CRO Services Sales Value, 2021–2032

6.7.2 South Korea Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Pharmaceutical CRO Services Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Pharmaceutical CRO Services Sales Value, 2021–2032

6.8.2 Southeast Asia Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Pharmaceutical CRO Services Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Pharmaceutical CRO Services Sales Value, 2021–2032

6.9.2 India Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

6.9.3 India Pharmaceutical CRO Services Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 PPD (Thermo Fisher)

7.1.1 PPD (Thermo Fisher) Profile

7.1.2 PPD (Thermo Fisher) Main Business

7.1.3 PPD (Thermo Fisher) Pharmaceutical CRO Services Products, Services, and Solutions

7.1.4 PPD (Thermo Fisher) Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.1.5 PPD (Thermo Fisher) Recent Developments

7.2 Space Peptides

7.2.1 Space Peptides Profile

7.2.2 Space Peptides Main Business

7.2.3 Space Peptides Pharmaceutical CRO Services Products, Services, and Solutions

7.2.4 Space Peptides Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.2.5 Space Peptides Recent Developments

7.3 Aurigene Pharmaceutical Services

7.3.1 Aurigene Pharmaceutical Services Profile

7.3.2 Aurigene Pharmaceutical Services Main Business

7.3.3 Aurigene Pharmaceutical Services Pharmaceutical CRO Services Products, Services, and Solutions

7.3.4 Aurigene Pharmaceutical Services Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.3.5 Aurigene Pharmaceutical Services Recent Developments

7.4 IQVIA

7.4.1 IQVIA Profile

7.4.2 IQVIA Main Business

7.4.3 IQVIA Pharmaceutical CRO Services Products, Services, and Solutions

7.4.4 IQVIA Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.4.5 IQVIA Recent Developments

7.5 Labcorp Drug Development

7.5.1 Labcorp Drug Development Profile

7.5.2 Labcorp Drug Development Main Business

7.5.3 Labcorp Drug Development Pharmaceutical CRO Services Products, Services, and Solutions

7.5.4 Labcorp Drug Development Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.5.5 Labcorp Drug Development Recent Developments

7.6 Parexel

7.6.1 Parexel Profile

7.6.2 Parexel Main Business

7.6.3 Parexel Pharmaceutical CRO Services Products, Services, and Solutions

7.6.4 Parexel Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.6.5 Parexel Recent Developments

7.7 ICON plc

7.7.1 ICON plc Profile

7.7.2 ICON plc Main Business

7.7.3 ICON plc Pharmaceutical CRO Services Products, Services, and Solutions

7.7.4 ICON plc Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.7.5 ICON plc Recent Developments

7.8 Syneos Health

7.8.1 Syneos Health Profile

7.8.2 Syneos Health Main Business

7.8.3 Syneos Health Pharmaceutical CRO Services Products, Services, and Solutions

7.8.4 Syneos Health Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.8.5 Syneos Health Recent Developments

7.9 Charles River Laboratories

7.9.1 Charles River Laboratories Profile

7.9.2 Charles River Laboratories Main Business

7.9.3 Charles River Laboratories Pharmaceutical CRO Services Products, Services, and Solutions

7.9.4 Charles River Laboratories Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.9.5 Charles River Laboratories Recent Developments

7.10 Medpace

7.10.1 Medpace Profile

7.10.2 Medpace Main Business

7.10.3 Medpace Pharmaceutical CRO Services Products, Services, and Solutions

7.10.4 Medpace Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.10.5 Medpace Recent Developments

7.11 SGS SA

7.11.1 SGS SA Profile

7.11.2 SGS SA Main Business

7.11.3 SGS SA Pharmaceutical CRO Services Products, Services, and Solutions

7.11.4 SGS SA Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.11.5 SGS SA Recent Developments

7.12 KCR CRO

7.12.1 KCR CRO Profile

7.12.2 KCR CRO Main Business

7.12.3 KCR CRO Pharmaceutical CRO Services Products, Services, and Solutions

7.12.4 KCR CRO Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.12.5 KCR CRO Recent Developments

7.13 TFS HealthScience

7.13.1 TFS HealthScience Profile

7.13.2 TFS HealthScience Main Business

7.13.3 TFS HealthScience Pharmaceutical CRO Services Products, Services, and Solutions

7.13.4 TFS HealthScience Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.13.5 TFS HealthScience Recent Developments

7.14 Caidya

7.14.1 Caidya Profile

7.14.2 Caidya Main Business

7.14.3 Caidya Pharmaceutical CRO Services Products, Services, and Solutions

7.14.4 Caidya Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.14.5 Caidya Recent Developments

7.15 Worldwide Clinical Trials

7.15.1 Worldwide Clinical Trials Profile

7.15.2 Worldwide Clinical Trials Main Business

7.15.3 Worldwide Clinical Trials Pharmaceutical CRO Services Products, Services, and Solutions

7.15.4 Worldwide Clinical Trials Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.15.5 Worldwide Clinical Trials Recent Developments

7.16 CTI

7.16.1 CTI Profile

7.16.2 CTI Main Business

7.16.3 CTI Pharmaceutical CRO Services Products, Services, and Solutions

7.16.4 CTI Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.16.5 CTI Recent Developments

7.17 Advanced Clinical

7.17.1 Advanced Clinical Profile

7.17.2 Advanced Clinical Main Business

7.17.3 Advanced Clinical Pharmaceutical CRO Services Products, Services, and Solutions

7.17.4 Advanced Clinical Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.17.5 Advanced Clinical Recent Developments

7.18 WuXi AppTec

7.18.1 WuXi AppTec Profile

7.18.2 WuXi AppTec Main Business

7.18.3 WuXi AppTec Pharmaceutical CRO Services Products, Services, and Solutions

7.18.4 WuXi AppTec Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.18.5 WuXi AppTec Recent Developments

7.19 Pharmaron Inc.

7.19.1 Pharmaron Inc. Profile

7.19.2 Pharmaron Inc. Main Business

7.19.3 Pharmaron Inc. Pharmaceutical CRO Services Products, Services, and Solutions

7.19.4 Pharmaron Inc. Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.19.5 Pharmaron Inc. Recent Developments

7.20 Hangzhou Tigermed Consulting

7.20.1 Hangzhou Tigermed Consulting Profile

7.20.2 Hangzhou Tigermed Consulting Main Business

7.20.3 Hangzhou Tigermed Consulting Pharmaceutical CRO Services Products, Services, and Solutions

7.20.4 Hangzhou Tigermed Consulting Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.20.5 Hangzhou Tigermed Consulting Recent Developments

7.21 JOINN Laboratories

7.21.1 JOINN Laboratories Profile

7.21.2 JOINN Laboratories Main Business

7.21.3 JOINN Laboratories Pharmaceutical CRO Services Products, Services, and Solutions

7.21.4 JOINN Laboratories Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.21.5 JOINN Laboratories Recent Developments

7.22 MEDICILON

7.22.1 MEDICILON Profile

7.22.2 MEDICILON Main Business

7.22.3 MEDICILON Pharmaceutical CRO Services Products, Services, and Solutions

7.22.4 MEDICILON Pharmaceutical CRO Services Revenue (US$ Million), 2021–2026

7.22.5 MEDICILON Recent Developments

8 Industry Chain Analysis

8.1 Pharmaceutical CRO Services Value Chain

8.2 Pharmaceutical CRO Services Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Pharmaceutical CRO Services Sales Model

8.5.2 Sales Channels

8.5.3 Pharmaceutical CRO Services Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Pharmaceutical CRO Services Market Trends

Table 2. Pharmaceutical CRO Services Market Drivers & Opportunities

Table 3. Pharmaceutical CRO Services Market Challenges

Table 4. Pharmaceutical CRO Services Market Restraints

Table 5. Global Pharmaceutical CRO Services Revenue by Company (US$ Million), 2021–2026

Table 6. Global Pharmaceutical CRO Services Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Pharmaceutical CRO Services Product Type

Table 9. Key Companies General Availability (GA) Timeline for Pharmaceutical CRO Services

Table 10. Global Pharmaceutical CRO Services Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical CRO Services revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Pharmaceutical CRO Services Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Pharmaceutical CRO Services Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Pharmaceutical CRO Services Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Pharmaceutical CRO Services Sales Market Share in Value by Type (2021–2026)

Table 17. Global Pharmaceutical CRO Services Sales Market Share in Value by Type (2027–2032)

Table 18. Global Pharmaceutical CRO Services Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Pharmaceutical CRO Services Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Pharmaceutical CRO Services Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Pharmaceutical CRO Services Sales Market Share in Value by Application (2021–2026)

Table 22. Global Pharmaceutical CRO Services Sales Market Share in Value by Application (2027–2032)

Table 23. Global Pharmaceutical CRO Services Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Pharmaceutical CRO Services Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Pharmaceutical CRO Services Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Pharmaceutical CRO Services Sales Value by Region (%), 2021–2026

Table 27. Global Pharmaceutical CRO Services Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Pharmaceutical CRO Services Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Pharmaceutical CRO Services Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Pharmaceutical CRO Services Sales Value, (US$ Million), 2027–2032

Table 31. PPD (Thermo Fisher) Basic Information List

Table 32. PPD (Thermo Fisher) Description and Business Overview

Table 33. PPD (Thermo Fisher) Pharmaceutical CRO Services Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Pharmaceutical CRO Services Business of PPD (Thermo Fisher) (2021–2026)

Table 35. PPD (Thermo Fisher) Recent Developments

Table 36. Space Peptides Basic Information List

Table 37. Space Peptides Description and Business Overview

Table 38. Space Peptides Pharmaceutical CRO Services Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Space Peptides (2021–2026)

Table 40. Space Peptides Recent Developments

Table 41. Aurigene Pharmaceutical Services Basic Information List

Table 42. Aurigene Pharmaceutical Services Description and Business Overview

Table 43. Aurigene Pharmaceutical Services Pharmaceutical CRO Services Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Aurigene Pharmaceutical Services (2021–2026)

Table 45. Aurigene Pharmaceutical Services Recent Developments

Table 46. IQVIA Basic Information List

Table 47. IQVIA Description and Business Overview

Table 48. IQVIA Pharmaceutical CRO Services Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Pharmaceutical CRO Services Business of IQVIA (2021–2026)

Table 50. IQVIA Recent Developments

Table 51. Labcorp Drug Development Basic Information List

Table 52. Labcorp Drug Development Description and Business Overview

Table 53. Labcorp Drug Development Pharmaceutical CRO Services Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Labcorp Drug Development (2021–2026)

Table 55. Labcorp Drug Development Recent Developments

Table 56. Parexel Basic Information List

Table 57. Parexel Description and Business Overview

Table 58. Parexel Pharmaceutical CRO Services Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Parexel (2021–2026)

Table 60. Parexel Recent Developments

Table 61. ICON plc Basic Information List

Table 62. ICON plc Description and Business Overview

Table 63. ICON plc Pharmaceutical CRO Services Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Pharmaceutical CRO Services Business of ICON plc (2021–2026)

Table 65. ICON plc Recent Developments

Table 66. Syneos Health Basic Information List

Table 67. Syneos Health Description and Business Overview

Table 68. Syneos Health Pharmaceutical CRO Services Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Syneos Health (2021–2026)

Table 70. Syneos Health Recent Developments

Table 71. Charles River Laboratories Basic Information List

Table 72. Charles River Laboratories Description and Business Overview

Table 73. Charles River Laboratories Pharmaceutical CRO Services Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Charles River Laboratories (2021–2026)

Table 75. Charles River Laboratories Recent Developments

Table 76. Medpace Basic Information List

Table 77. Medpace Description and Business Overview

Table 78. Medpace Pharmaceutical CRO Services Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Medpace (2021–2026)

Table 80. Medpace Recent Developments

Table 81. SGS SA Basic Information List

Table 82. SGS SA Description and Business Overview

Table 83. SGS SA Pharmaceutical CRO Services Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Pharmaceutical CRO Services Business of SGS SA (2021–2026)

Table 85. SGS SA Recent Developments

Table 86. KCR CRO Basic Information List

Table 87. KCR CRO Description and Business Overview

Table 88. KCR CRO Pharmaceutical CRO Services Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Pharmaceutical CRO Services Business of KCR CRO (2021–2026)

Table 90. KCR CRO Recent Developments

Table 91. TFS HealthScience Basic Information List

Table 92. TFS HealthScience Description and Business Overview

Table 93. TFS HealthScience Pharmaceutical CRO Services Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Pharmaceutical CRO Services Business of TFS HealthScience (2021–2026)

Table 95. TFS HealthScience Recent Developments

Table 96. Caidya Basic Information List

Table 97. Caidya Description and Business Overview

Table 98. Caidya Pharmaceutical CRO Services Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Caidya (2021–2026)

Table 100. Caidya Recent Developments

Table 101. Worldwide Clinical Trials Basic Information List

Table 102. Worldwide Clinical Trials Description and Business Overview

Table 103. Worldwide Clinical Trials Pharmaceutical CRO Services Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Worldwide Clinical Trials (2021–2026)

Table 105. Worldwide Clinical Trials Recent Developments

Table 106. CTI Basic Information List

Table 107. CTI Description and Business Overview

Table 108. CTI Pharmaceutical CRO Services Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Pharmaceutical CRO Services Business of CTI (2021–2026)

Table 110. CTI Recent Developments

Table 111. Advanced Clinical Basic Information List

Table 112. Advanced Clinical Description and Business Overview

Table 113. Advanced Clinical Pharmaceutical CRO Services Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Advanced Clinical (2021–2026)

Table 115. Advanced Clinical Recent Developments

Table 116. WuXi AppTec Basic Information List

Table 117. WuXi AppTec Description and Business Overview

Table 118. WuXi AppTec Pharmaceutical CRO Services Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Pharmaceutical CRO Services Business of WuXi AppTec (2021–2026)

Table 120. WuXi AppTec Recent Developments

Table 121. Pharmaron Inc. Basic Information List

Table 122. Pharmaron Inc. Description and Business Overview

Table 123. Pharmaron Inc. Pharmaceutical CRO Services Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Pharmaron Inc. (2021–2026)

Table 125. Pharmaron Inc. Recent Developments

Table 126. Hangzhou Tigermed Consulting Basic Information List

Table 127. Hangzhou Tigermed Consulting Description and Business Overview

Table 128. Hangzhou Tigermed Consulting Pharmaceutical CRO Services Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Hangzhou Tigermed Consulting (2021–2026)

Table 130. Hangzhou Tigermed Consulting Recent Developments

Table 131. JOINN Laboratories Basic Information List

Table 132. JOINN Laboratories Description and Business Overview

Table 133. JOINN Laboratories Pharmaceutical CRO Services Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Pharmaceutical CRO Services Business of JOINN Laboratories (2021–2026)

Table 135. JOINN Laboratories Recent Developments

Table 136. MEDICILON Basic Information List

Table 137. MEDICILON Description and Business Overview

Table 138. MEDICILON Pharmaceutical CRO Services Products, Services, and Solutions

Table 139. Revenue (US$ Million) in Pharmaceutical CRO Services Business of MEDICILON (2021–2026)

Table 140. MEDICILON Recent Developments

Table 141. Revenue (US$ Million) in Pharmaceutical CRO Services Business of Company 40 (2021–2026)

Table 142. Company 40 Recent Developments

Table 143. Key Raw Materials Lists

Table 144. Key Suppliers of Raw Materials Lists

Table 145. Pharmaceutical CRO Services Downstream Customers

Table 146. Pharmaceutical CRO Services Distributors List

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceutical CRO Services Product Picture

Figure 2. Global Pharmaceutical CRO Services Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 4. Pharmaceutical CRO Services Report Years Considered

Figure 5. Global Pharmaceutical CRO Services Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharmaceutical CRO Services Revenue in 2025

Figure 7. Pharmaceutical CRO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Preclinical CRO Picture

Figure 9. Clinical Trial CRO Picture

Figure 10. Global Pharmaceutical CRO Services Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Pharmaceutical CRO Services Sales Value Market Share by Type, 2025 & 2032

Figure 12. Product Picture of Commercial

Figure 13. Product Picture of Scientific Research

Figure 14. Product Picture of Other

Figure 15. Global Pharmaceutical CRO Services Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Pharmaceutical CRO Services Sales Value Market Share by Application, 2025 & 2032

Figure 17. North America Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 18. North America Pharmaceutical CRO Services Sales Value by Country (%), 2025 vs 2032

Figure 19. Europe Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 20. Europe Pharmaceutical CRO Services Sales Value by Country (%), 2025 vs 2032

Figure 21. Asia Pacific Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 22. Asia Pacific Pharmaceutical CRO Services Sales Value by Subregion (%), 2025 vs 2032

Figure 23. South America Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 24. South America Pharmaceutical CRO Services Sales Value by Country (%), 2025 vs 2032

Figure 25. Middle East & Africa Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 26. Middle East & Africa Pharmaceutical CRO Services Sales Value by Country (%), 2025 vs 2032

Figure 27. Key Countries/Regions Pharmaceutical CRO Services Sales Value (%), 2021–2032

Figure 28. United States Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 29. United States Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

Figure 30. United States Pharmaceutical CRO Services Sales Value by Application (%), 2025 vs 2032

Figure 31. Europe Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 32. Europe Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

Figure 33. Europe Pharmaceutical CRO Services Sales Value by Application (%), 2025 vs 2032

Figure 34. China Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 35. China Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

Figure 36. China Pharmaceutical CRO Services Sales Value by Application (%), 2025 vs 2032

Figure 37. Japan Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 38. Japan Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

Figure 39. Japan Pharmaceutical CRO Services Sales Value by Application (%), 2025 vs 2032

Figure 40. South Korea Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 41. South Korea Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

Figure 42. South Korea Pharmaceutical CRO Services Sales Value by Application (%), 2025 vs 2032

Figure 43. Southeast Asia Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 44. Southeast Asia Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

Figure 45. Southeast Asia Pharmaceutical CRO Services Sales Value by Application (%), 2025 vs 2032

Figure 46. India Pharmaceutical CRO Services Sales Value (US$ Million), 2021–2032

Figure 47. India Pharmaceutical CRO Services Sales Value by Type (%), 2025 vs 2032

Figure 48. India Pharmaceutical CRO Services Sales Value by Application (%), 2025 vs 2032

Figure 49. Pharmaceutical CRO Services Value Chain

Figure 50. Pharmaceutical CRO Services Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmaceutical CRO Services market? zhanKai

The top companies in the global Pharmaceutical CRO Services market are PPD (Thermo Fisher)、Space Peptides、Aurigene Pharmaceutical Services.

Related Reports

Global Pharmaceutical CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharmaceutical CRO Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 168
USD 4900.00
(Single User License)
Global Pharmaceutical CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical CRO Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 116
USD 4250.00
(Single User License)
Global Pharmaceutical CRO Services Market Research Report 2026
The global Pharmaceutical CRO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 144
USD 2900.00
(Single User License)
Global Pharmaceutical CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical CRO Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 113
USD 4250.00
(Single User License)
Global Pharmaceutical CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical CRO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 171
USD 4900.00
(Single User License)
Pharmaceutical CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical CRO Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 146
USD 3950.00
(Single User License)
Global Pharmaceutical CRO Services Market Research Report 2025
The global market for Pharmaceutical CRO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 105
USD 2900.00
(Single User License)
Global Pharmaceutical CRO Services Market Research Report 2024
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published Date: 2024-06-15
Pages: 101
USD 2900.00
(Single User License)
Global Pharmaceutical CRO Services Market Insights, Forecast to 2030
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published Date: 2024-06-15
Pages: 164
USD 4900.00
(Single User License)
Pharmaceutical CRO Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published Date: 2024-06-15
Pages: 142
USD 3950.00
(Single User License)

Global Pharmaceutical CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharmaceutical CRO Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 168
USD 4900.00 (Single User License)
Global Pharmaceutical CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical CRO Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 116
USD 4250.00 (Single User License)
Global Pharmaceutical CRO Services Market Research Report 2026
The global Pharmaceutical CRO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 144
USD 2900.00 (Single User License)
Global Pharmaceutical CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical CRO Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 113
USD 4250.00 (Single User License)
Global Pharmaceutical CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical CRO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 171
USD 4900.00 (Single User License)
Pharmaceutical CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical CRO Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 146
USD 3950.00 (Single User License)
Global Pharmaceutical CRO Services Market Research Report 2025
The global market for Pharmaceutical CRO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 105
USD 2900.00 (Single User License)
Global Pharmaceutical CRO Services Market Research Report 2024
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published: 2024-06-15
Pages: 101
USD 2900.00 (Single User License)
Global Pharmaceutical CRO Services Market Insights, Forecast to 2030
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published: 2024-06-15
Pages: 164
USD 4900.00 (Single User License)
Pharmaceutical CRO Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published: 2024-06-15
Pages: 142
USD 3950.00 (Single User License)